Novartis Wins Ruling On Duty-To-Warn Scope In Zometa Suit
A Florida federal court on Tuesday granted Novartis Pharmaceuticals Corp.'s request to exclude evidence and argument on claims that it had a duty to warn people beyond the prescribing physician of...To view the full article, register now.
Already a subscriber? Click here to view full article